intelycare.comHealthcare / Healthcare providers & servicesFounded: 2015Funding to Date: $172.93MM
IntelyCare, founded in 2016, is a technology company that seeks to provide a workforce management solution for post-acute healthcare facilities. The platform aims to leverage machine learning to streamline staff scheduling and efficiently fill nursing shifts, with the goal of improving workforce productivity and patient care. By harnessing the power of technology, IntelyCare strives to address the challenges of staffing in healthcare, ensuring that facilities are optimally staffed at all times. IntelyCare is headquartered in Quincy, Massachusetts.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
04/06/2022 | Series C | $121.1MM | $xx.xx | $1.11B | Endeavour Vision, Janus Henderson Ivestors, Kaiser Permanente Ventures, Leeds Illuminate, Longitude Capital, Revelation Partners | |
Price per Share
$xx.xx
Shares Outstanding
4,943,716
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Endeavour Vision, Janus Henderson Ivestors, Kaiser Permanente Ventures, Leeds Illuminate, Longitude Capital, Revelation Partners
|
||||||
02/20/2020 | Series B | $36.42MM | $xx.xx | $107.24MM | Endeavour Vision, Generator Ventures, Kaiser Permanente Ventures | |
Price per Share
$xx.xx
Shares Outstanding
13,186,057
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Endeavour Vision, Generator Ventures, Kaiser Permanente Ventures
|
||||||
11/01/2018 | Series A | $11.55MM | $xx.xx | $27MM | Bill Mantzoukas, Leerink Revelation Partners, Longmeadow Capital, Lrvhealth | |
Price per Share
$xx.xx
Shares Outstanding
10,310,819
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bill Mantzoukas, Leerink Revelation Partners, Longmeadow Capital, Lrvhealth
|
||||||
12/29/2016 | Series Seed | $3.86MM | $xx.xx | $15.46MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,740,966
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|